Until RCT proven? On the asymmetry of evidence requirements for risk assessment.
about
How to review a surgical paper: a guide for junior referees.Safety vs. efficacy assessment of pharmaceuticals: Epistemological rationales and methodsResearch report appraisal: how much understanding is enough?Bridging the boundaries between scientists and clinicians-mechanistic hypotheses and patient stories in risk assessment of drugs.Explanation, understanding, objectivity and experience.What's in a gold standard? In defence of randomised controlled trials.
P2860
Until RCT proven? On the asymmetry of evidence requirements for risk assessment.
description
2013 nî lūn-bûn
@nan
2013年の論文
@ja
2013年学术文章
@wuu
2013年学术文章
@zh-cn
2013年学术文章
@zh-hans
2013年学术文章
@zh-my
2013年学术文章
@zh-sg
2013年學術文章
@yue
2013年學術文章
@zh
2013年學術文章
@zh-hant
name
Until RCT proven? On the asymmetry of evidence requirements for risk assessment.
@en
Until RCT proven? On the asymmetry of evidence requirements for risk assessment.
@nl
type
label
Until RCT proven? On the asymmetry of evidence requirements for risk assessment.
@en
Until RCT proven? On the asymmetry of evidence requirements for risk assessment.
@nl
prefLabel
Until RCT proven? On the asymmetry of evidence requirements for risk assessment.
@en
Until RCT proven? On the asymmetry of evidence requirements for risk assessment.
@nl
P2860
P356
P1476
Until RCT proven? On the asymmetry of evidence requirements for risk assessment.
@en
P2093
Barbara Osimani
P2860
P304
P356
10.1111/JEP.12039
P577
2013-06-01T00:00:00Z